Evaluation of Antidepressant-like Effect of Olax Subscorpioidea Oliv. (Olacaceae) Extract in Mice

Abstract

Olax subscorpioidea is a shrub or tree found in Nigeria, and other parts of Africa. It is indicated in the management of inflammatory disorder, mental illness, convulsion, pain, and cancer.

Based on the folkloric use in the management of mental illness, antidepressant activity of Olax subscorpioidea (6.25–50 mg/kg, i. p.) was investigated using forced swimming, tail suspension, yohimbine induced lethality and reserpine induced depression tests.

The results showed that, Olax subscorpioidea produced significant dose dependent reduction in immobility time in forced swimming [F (5, 24)=17.22, p<0.0001] and tail suspension [F (5, 24)=14.94, p<0.0001] tests without causing changes in locomotor activity in open field test. It was also found that Olax subscorpioidea significantly reduced diarrhea in reserpine model of depression [F (5, 24)=10, p<0.0001]. None of the doses potentiated yohimbine induced lethality in mice. In conclusion Olax subscorpioidea possessed antidepressant action, thus justifying its use in the management of mental illness.

Key words

antidepressant - mental illness - immobility - Olax subscorpioidea - yohimbine

• References

• 1 Lépine JP, Briley M. The increasing burden of depression Neuropsychiatric Disease and Treatment 2011; 3-1
• 2 WHO . Mental and Neurological Disorders. Fact sheet No. 25. World Health Organization; 1998
• 3 Richelson E. Mayo Clin Proc 2001; 76: 516-527
• 4 Ebmeier KP, Donaghey C, Steele JC. Recent developments and current controversies in depression. Lancet 2006; 367: 153-167
• 5 Nestler EJ, Barrot M, DiLeone RJ et al. Neurobiology of depression. Neuron 2002; 34: 13-25
• 6 Dhingra S, Parle M. Herbal remedies and nutritional supplements in the treatment of depression: a review. Bulletin of Clinical Psychopharmacology 2012; 22: 286-292
• 7 Kessler RC, Chiu WT, Demler O et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey. Replication Arch Gen Psychiatry 2005; 62: 617-627
• 8 Bouquet A. Féticheurs et médecines traditionnelles du Congo (Brazzaville) Mém. O R S T O M 1969; (36) 282 http://www.docstoc.com/docs/41737230/Ficheurs-et-mecines-traditionn
• 9 Sonibare MA, Gbile ZO. Ethnobotanical survey of anti-asthmatic plants in south western Nigeria Afr. J Trad CAM 2008; 5: 340-345
• 10 Mike OS, Amusa NA, Raji-Esan SO et al. Ethnobotanical Survey of Anti-Cancer Plants in Ogun State. Nigeria Annals of Biological Research 2010; 1: 261-273
• 11 Ibrahim JA, Muazzam I, Jegede IA et al. Ethno-medicinal plants and methods used by Gwandara tribe of Sabo Wuse in Niger state. Nigeria, to treat mental illness African Journal of Traditional, Complementary and Alternative Medicines 2007; 4: 211-218
• 12 Ayandele AA, Adebiyi AO. The phytochemical analysis and antimicrobial screening of extracts of olax subscorpioidea. African Journal of Biotechnology 2007; 6: 868-870
• 13 Lorke D. A new approach to practical acute toxicity testing. Arch Technol 1983; 54: 275-282
• 14 Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977; 229: 326-327
• 15 Rodrigues ALS, Silva GL, Matteussi AS et al. Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus. Life Sci 2002; 70: 1347-1358
• 16 Rodrigues AL, Rocha JB, Mello CF et al. Effect of perinatal lead exposure on rat behavior in open-field and two-way avoidance tasks. Pharmacol Toxicol 1996; 79: 150-156
• 17 Voger HG, Voger WH. Drug Discovery and Evaluation-Pharmacological Assays; antidepressant activity. Springer-Verlag; Berlin heidelberg: 1997: 411
• 18 Xu Q, Yi LT, Pan Y et al. Antidepressant-like effects of mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 715-725
• 19 Cryan JF, Mombereau C, Vassout A. The tail suspension test as a model to assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 2005; 29: 571
• 20 Porsolt RD. Behavioural Despair, in antidepressants: Neurochemical, behavioural and clinical Perspectives. Ed by Enna SJ, Malick JB, Richelson E. Raven Press; New York: 1981: 121-139
• 21 Steru L, Chermat R, Thierry B. The automated tail suspension test: a computerized device which differentiates psychotropic drugs Prog Neuropsychopharmacol. Biol Psychiatry 1987; 11: 659-671
• 22 Cryan JF, Lucki I. Antidepressant-like behavioral effects mediated by 5- hydroxytry-ptamine(2C) receptors. Journal of Pharmacology and Experimental Therapeutics 2000; 295: 1120-1126
• 23 Cryan JF, Markou A, Lucki I. Assessing antidepressant activity in rodents: recent developments and future need. Trends in Pharmacological Sciences 2002; 23: 238-245
• 24 Porsolt RD, Anton G, Blavet N et al. Behavioral despair in rats A new animal model sensitive to antidepressive treatments. Eur J Pharmacol 1978; 47: 379-391
• 25 Varty GB, Cohen-Williams ME, Hunter JC. The antidepressant- like effects of neurokinin NK1 receptor antagonists in a gerbil tail suspension test. Behav Pharmacol 2003; 14: 87-95
• 26 Lucki I. A prescription to resist proscriptions for murine models of depression. Psychopharmacology 2001; 153: 395-398
• 27 Bourin M, Fiocco AJ, Clenet F. How valuable are animal models in defining antidepressant activity?. Hum Psychopharmacol 2001; 16: 9-21
• 28 Boissier JR, Simon P. Action of caffeine on the spontaneous motility of the mouse. Arch Int Pharmacodyn Ther 1965; 158: 212-221
• 29 Butterweck V, Christoffel V, Nahrsted A et al. Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models. Life Sci 2003; 73: 627-639
• 30 Takahashi E, Katayama M, Nimii K et al. Additive sub threshold dose effects of cannabinoid CB1 receptor antagonist and selective serotonin re uptake inhibitor in antidepressant behavioral tests. Euro J Pharmacol 2008; 589: 149-156
• 31 Kwon S, Lee B, Kim M et al. Antidepressant-like effect of the methanolic extract from Bupleurum falcatum in the tail suspension test Prog Neuropsychopharmacol. Biol Psychiatry 2009; 34: 265-270
• 32 Borsini F, Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity?. Psychopharmacology 1988; 94: 147-160
• 33 Cervo L, Samanin R. Evidence that dopamine mechanisms in the nucleus accumbens are selectively involved in the effect of desipramine in the forced swimming test. Neuropharamcology 1987; 26: 1469
• 34 Sánchez-Mateo CC, Bonkanka CX, Prado B et al. Antidepressan properties of some Hypericum canariense L and Hypericum glandulosum Ait Extracts in the forced swimming test in mice. J Ethnopharmacol 2005; 97: 541-547
• 35 Leonard BE. Mechanism of action of antidepressants: relevance to understanding the psychobiology of depression?. Clin Neuropharmacol 1986; 9: 67-69
• 36 Blier P, Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sc 1994; 15: 220-226
• 37 Malick JB. Potentiation of Yohimbine-induced lethality in mice: predictor of antidepressant potential. Drug Dev Res 1983; 3: 357-363
• 38 Bourin M, Poncelet M, Chermat R et al. The value of the reserpine test in psychopharmacology. Arzneimittel-Forschung/Drug Research 1983; 33: 1173-1176